Lataa...
Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond
The use of recombinant adeno-associated viruses (rAAVs) ushered in a new millennium of gene transfer for therapeutic treatment of a number of conditions, including congenital blindness, hemophilia, and spinal muscular atrophy. rAAV vectors have remarkable staying power from a therapeutic standpoint,...
Tallennettuna:
| Julkaisussa: | Hum Gene Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Mary Ann Liebert, Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5399734/ https://ncbi.nlm.nih.gov/pubmed/28073291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2016.171 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|